Dr. Anthony Luz joined Integral Consulting Inc. after completing his Ph.D. in toxicology from Duke University and a postdoctoral fellowship with the National Toxicology Program. He has 6 years of experience designing and interpreting results from in vitro toxicology studies, specifically related to the use of human embryonic stem cells and Caenorhabditis elegans. Dr. Luz’s primary focus is on per- and polyfluoroalkyl substances (PFAS) and other emerging contaminants. Dr. Luz has assessed the toxicology of numerous legacy and short-chain PFAS to support hazard and data gap identification efforts. He has published his work on emerging contaminants in peer-reviewed journals and presented it at several national conferences.
Anthony L. Luz, Ph.D.